Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Eckhard Podack
🇩🇪
Germany
Country
🇩🇪
Germany
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
Phase 1
Withdrawn
Conditions
Non-small-cell Lung Carcinoma
Lung Cancer
NSCLC
Non-Small Cell Lung Cancer
Interventions
Biological: gp96-Ig Vaccine
Drug: Theophylline
Other: Oxygen
Procedure: Immunologic Evaluation
Subscribe
First Posted Date
2013-02-26
Last Posted Date
2014-11-17
Lead Sponsor
Eckhard Podack
Registration Number
NCT01799161
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy